aluates Reports

$ 0.0

Automative

Global Untargeted Metabolomics Market Research Report 2026

Published Date: 2026-01-20

Report Code: QYRE-Auto-14S18902

Global Untargeted Metabolomics Market Research Report 2024

BUY CHAPTERS

Global Untargeted Metabolomics Market Research Report 2026

Code: QYRE-Auto-14S18902

Report

2026-01-20

Pages:112

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Creative Dynamics Inc (Creative Proteomics)

Metabolon

Alfa Chemistry

Novelgene Technologies

MtoZ-Biolabs Inc.

CD Genomics

Metware Biotechnology Inc (Metware)

BGI Genomics

Applied Protein Technology

Suzhou PANOMIX Biomedical Tech Co.,Ltd

OBiO Technology ( Shanghai ) Corp.,Ltd.

Abace Biotechnology

Beijing Huayi innovation & BioTechnology Co., Ltd

Metabo-Profile

Beijing Huayi innovation & BioTechnology Co., Ltd

Untargeted Metabolomics Market Size

The global Untargeted Metabolomics market was valued at US$ 1656 million in 2025 and is anticipated to reach US$ 3162 million by 2032, at a CAGR of 9.8% from 2026 to 2032.

Untargeted Metabolomics Market

Untargeted metabolomics is a study in which all detectable metabolites are identified and quantitated for analyzing the overall metabolic characteristics and discovering metabolic mechanisms behind the phenomenon. Also known as discovery metabolomics, untargeted metabolomics is a powerful tool for large-scale early phase diagnosis and discovery of new biomarkers. Compared to traditional metabolic quantitation methods, untargeted metabolomics is a high-throughput technology, enabling more comprehensive analysis with more accurate data acquisition, eliminating biased research direction.

The North American market for Untargeted Metabolomics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Untargeted Metabolomics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Untargeted Metabolomics in Academic and Research Institutions is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Untargeted Metabolomics include Creative Dynamics Inc (Creative Proteomics), Metabolon, Alfa Chemistry, Novelgene Technologies, MtoZ-Biolabs Inc., CD Genomics, Metware Biotechnology Inc (Metware), BGI Genomics, APPLIED PROTEIN TECHNOLOGY, Suzhou PANOMIX Biomedical Tech Co.,Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Untargeted Metabolomics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Untargeted Metabolomics. The Untargeted Metabolomics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Untargeted Metabolomics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Untargeted Metabolomics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Untargeted Metabolomics Market Report

Report Metric	Details
Report Name	Untargeted Metabolomics Market
Accounted market size in 2025	US$ 1656 million
Forecasted market size in 2032	US$ 3162 million
CAGR	9.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Plant Untargeted Metabolomics Human Untargeted Metabolomics Other
Segment by Application	Academic and Research Institutions Pharmaceutical and Biotechnology Companies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Creative Dynamics Inc (Creative Proteomics), Metabolon, Alfa Chemistry, Novelgene Technologies, MtoZ-Biolabs Inc., CD Genomics, Metware Biotechnology Inc (Metware), BGI Genomics, APPLIED PROTEIN TECHNOLOGY, Suzhou PANOMIX Biomedical Tech Co.,Ltd, OBiO Technology ( Shanghai ) Corp.,Ltd., Beijing Huayi innovation & BioTechnology Co., Ltd, Abace Biotechnology, Metabo-Profile
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Untargeted Metabolomics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Untargeted Metabolomics Market growing?

Ans: The Untargeted Metabolomics Market witnessing a CAGR of 9.8% during the forecast period 2026-2032.

What is the Untargeted Metabolomics Market size in 2032?

Ans: The Untargeted Metabolomics Market size in 2032 will be US$ 3162 million.

Who are the main players in the Untargeted Metabolomics Market report?

Ans: The main players in the Untargeted Metabolomics Market are Creative Dynamics Inc (Creative Proteomics), Metabolon, Alfa Chemistry, Novelgene Technologies, MtoZ-Biolabs Inc., CD Genomics, Metware Biotechnology Inc (Metware), BGI Genomics, APPLIED PROTEIN TECHNOLOGY, Suzhou PANOMIX Biomedical Tech Co.,Ltd, OBiO Technology ( Shanghai ) Corp.,Ltd., Beijing Huayi innovation & BioTechnology Co., Ltd, Abace Biotechnology, Metabo-Profile

What are the Application segmentation covered in the Untargeted Metabolomics Market report?

Ans: The Applications covered in the Untargeted Metabolomics Market report are Academic and Research Institutions, Pharmaceutical and Biotechnology Companies

What are the Type segmentation covered in the Untargeted Metabolomics Market report?

Ans: The Types covered in the Untargeted Metabolomics Market report are Plant Untargeted Metabolomics, Human Untargeted Metabolomics, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Untargeted Metabolomics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Plant Untargeted Metabolomics

1.2.3 Human Untargeted Metabolomics

1.2.4 Other

1.3 Market by Application

1.3.1 Global Untargeted Metabolomics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Academic and Research Institutions

1.3.3 Pharmaceutical and Biotechnology Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Untargeted Metabolomics Market Perspective (2021–2032)

2.2 Global Untargeted Metabolomics Growth Trends by Region

2.2.1 Global Untargeted Metabolomics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Untargeted Metabolomics Historic Market Size by Region (2021–2026)

2.2.3 Untargeted Metabolomics Forecasted Market Size by Region (2027–2032)

2.3 Untargeted Metabolomics Market Dynamics

2.3.1 Untargeted Metabolomics Industry Trends

2.3.2 Untargeted Metabolomics Market Drivers

2.3.3 Untargeted Metabolomics Market Challenges

2.3.4 Untargeted Metabolomics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Untargeted Metabolomics Players by Revenue

3.1.1 Global Top Untargeted Metabolomics Players by Revenue (2021–2026)

3.1.2 Global Untargeted Metabolomics Revenue Market Share by Players (2021–2026)

3.2 Global Top Untargeted Metabolomics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Untargeted Metabolomics Revenue

3.4 Global Untargeted Metabolomics Market Concentration Ratio

3.4.1 Global Untargeted Metabolomics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Untargeted Metabolomics Revenue in 2025

3.5 Global Key Players of Untargeted Metabolomics Head Offices and Areas Served

3.6 Global Key Players of Untargeted Metabolomics, Products and Applications

3.7 Global Key Players of Untargeted Metabolomics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Untargeted Metabolomics Breakdown Data by Type

4.1 Global Untargeted Metabolomics Historic Market Size by Type (2021–2026)

4.2 Global Untargeted Metabolomics Forecasted Market Size by Type (2027–2032)

5 Untargeted Metabolomics Breakdown Data by Application

5.1 Global Untargeted Metabolomics Historic Market Size by Application (2021–2026)

5.2 Global Untargeted Metabolomics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Untargeted Metabolomics Market Size (2021–2032)

6.2 North America Untargeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Untargeted Metabolomics Market Size by Country (2021–2026)

6.4 North America Untargeted Metabolomics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Untargeted Metabolomics Market Size (2021–2032)

7.2 Europe Untargeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Untargeted Metabolomics Market Size by Country (2021–2026)

7.4 Europe Untargeted Metabolomics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Untargeted Metabolomics Market Size (2021–2032)

8.2 Asia-Pacific Untargeted Metabolomics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Untargeted Metabolomics Market Size by Region (2021–2026)

8.4 Asia-Pacific Untargeted Metabolomics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Untargeted Metabolomics Market Size (2021–2032)

9.2 Latin America Untargeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Untargeted Metabolomics Market Size by Country (2021–2026)

9.4 Latin America Untargeted Metabolomics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Untargeted Metabolomics Market Size (2021–2032)

10.2 Middle East & Africa Untargeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Untargeted Metabolomics Market Size by Country (2021–2026)

10.4 Middle East & Africa Untargeted Metabolomics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Creative Dynamics Inc (Creative Proteomics)

11.1.1 Creative Dynamics Inc (Creative Proteomics) Company Details

11.1.2 Creative Dynamics Inc (Creative Proteomics) Business Overview

11.1.3 Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Introduction

11.1.4 Creative Dynamics Inc (Creative Proteomics) Revenue in Untargeted Metabolomics Business (2021–2026)

11.1.5 Creative Dynamics Inc (Creative Proteomics) Recent Development

11.2 Metabolon

11.2.1 Metabolon Company Details

11.2.2 Metabolon Business Overview

11.2.3 Metabolon Untargeted Metabolomics Introduction

11.2.4 Metabolon Revenue in Untargeted Metabolomics Business (2021–2026)

11.2.5 Metabolon Recent Development

11.3 Alfa Chemistry

11.3.1 Alfa Chemistry Company Details

11.3.2 Alfa Chemistry Business Overview

11.3.3 Alfa Chemistry Untargeted Metabolomics Introduction

11.3.4 Alfa Chemistry Revenue in Untargeted Metabolomics Business (2021–2026)

11.3.5 Alfa Chemistry Recent Development

11.4 Novelgene Technologies

11.4.1 Novelgene Technologies Company Details

11.4.2 Novelgene Technologies Business Overview

11.4.3 Novelgene Technologies Untargeted Metabolomics Introduction

11.4.4 Novelgene Technologies Revenue in Untargeted Metabolomics Business (2021–2026)

11.4.5 Novelgene Technologies Recent Development

11.5 MtoZ-Biolabs Inc.

11.5.1 MtoZ-Biolabs Inc. Company Details

11.5.2 MtoZ-Biolabs Inc. Business Overview

11.5.3 MtoZ-Biolabs Inc. Untargeted Metabolomics Introduction

11.5.4 MtoZ-Biolabs Inc. Revenue in Untargeted Metabolomics Business (2021–2026)

11.5.5 MtoZ-Biolabs Inc. Recent Development

11.6 CD Genomics

11.6.1 CD Genomics Company Details

11.6.2 CD Genomics Business Overview

11.6.3 CD Genomics Untargeted Metabolomics Introduction

11.6.4 CD Genomics Revenue in Untargeted Metabolomics Business (2021–2026)

11.6.5 CD Genomics Recent Development

11.7 Metware Biotechnology Inc (Metware)

11.7.1 Metware Biotechnology Inc (Metware) Company Details

11.7.2 Metware Biotechnology Inc (Metware) Business Overview

11.7.3 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Introduction

11.7.4 Metware Biotechnology Inc (Metware) Revenue in Untargeted Metabolomics Business (2021–2026)

11.7.5 Metware Biotechnology Inc (Metware) Recent Development

11.8 BGI Genomics

11.8.1 BGI Genomics Company Details

11.8.2 BGI Genomics Business Overview

11.8.3 BGI Genomics Untargeted Metabolomics Introduction

11.8.4 BGI Genomics Revenue in Untargeted Metabolomics Business (2021–2026)

11.8.5 BGI Genomics Recent Development

11.9 APPLIED PROTEIN TECHNOLOGY

11.9.1 APPLIED PROTEIN TECHNOLOGY Company Details

11.9.2 APPLIED PROTEIN TECHNOLOGY Business Overview

11.9.3 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Introduction

11.9.4 APPLIED PROTEIN TECHNOLOGY Revenue in Untargeted Metabolomics Business (2021–2026)

11.9.5 APPLIED PROTEIN TECHNOLOGY Recent Development

11.10 Suzhou PANOMIX Biomedical Tech Co.,Ltd

11.10.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Company Details

11.10.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Business Overview

11.10.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Introduction

11.10.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Revenue in Untargeted Metabolomics Business (2021–2026)

11.10.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Development

11.11 OBiO Technology ( Shanghai ) Corp.,Ltd.

11.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details

11.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview

11.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Introduction

11.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Untargeted Metabolomics Business (2021–2026)

11.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development

11.12 Beijing Huayi innovation & BioTechnology Co., Ltd

11.12.1 Beijing Huayi innovation & BioTechnology Co., Ltd Company Details

11.12.2 Beijing Huayi innovation & BioTechnology Co., Ltd Business Overview

11.12.3 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Introduction

11.12.4 Beijing Huayi innovation & BioTechnology Co., Ltd Revenue in Untargeted Metabolomics Business (2021–2026)

11.12.5 Beijing Huayi innovation & BioTechnology Co., Ltd Recent Development

11.13 Abace Biotechnology

11.13.1 Abace Biotechnology Company Details

11.13.2 Abace Biotechnology Business Overview

11.13.3 Abace Biotechnology Untargeted Metabolomics Introduction

11.13.4 Abace Biotechnology Revenue in Untargeted Metabolomics Business (2021–2026)

11.13.5 Abace Biotechnology Recent Development

11.14 Metabo-Profile

11.14.1 Metabo-Profile Company Details

11.14.2 Metabo-Profile Business Overview

11.14.3 Metabo-Profile Untargeted Metabolomics Introduction

11.14.4 Metabo-Profile Revenue in Untargeted Metabolomics Business (2021–2026)

11.14.5 Metabo-Profile Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Creative Dynamics Inc (Creative Proteomics)

Metabolon

Alfa Chemistry

Novelgene Technologies

MtoZ-Biolabs Inc.

CD Genomics

Metware Biotechnology Inc (Metware)

BGI Genomics

Applied Protein Technology

Suzhou PANOMIX Biomedical Tech Co.,Ltd

OBiO Technology ( Shanghai ) Corp.,Ltd.

Abace Biotechnology

Beijing Huayi innovation & BioTechnology Co., Ltd

Metabo-Profile

Beijing Huayi innovation & BioTechnology Co., Ltd

List of Tables

Table 1. Global Untargeted Metabolomics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Plant Untargeted Metabolomics

Table 3. Key Players of Human Untargeted Metabolomics

Table 4. Key Players of Other

Table 5. Global Untargeted Metabolomics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Untargeted Metabolomics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Untargeted Metabolomics Market Size by Region (US$ Million), 2021–2026

Table 8. Global Untargeted Metabolomics Market Share by Region (2021–2026)

Table 9. Global Untargeted Metabolomics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Untargeted Metabolomics Market Share by Region (2027–2032)

Table 11. Untargeted Metabolomics Market Trends

Table 12. Untargeted Metabolomics Market Drivers

Table 13. Untargeted Metabolomics Market Challenges

Table 14. Untargeted Metabolomics Market Restraints

Table 15. Global Untargeted Metabolomics Revenue by Players (US$ Million), 2021–2026

Table 16. Global Untargeted Metabolomics Market Share by Players (2021–2026)

Table 17. Global Top Untargeted Metabolomics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Untargeted Metabolomics Revenue, 2025

Table 18. Ranking of Global Top Untargeted Metabolomics Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Untargeted Metabolomics Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Untargeted Metabolomics, Headquarters and Area Served

Table 21. Global Key Players of Untargeted Metabolomics, Products and Applications

Table 22. Global Key Players of Untargeted Metabolomics, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Untargeted Metabolomics Market Size by Type (US$ Million), 2021–2026

Table 25. Global Untargeted Metabolomics Revenue Market Share by Type (2021–2026)

Table 26. Global Untargeted Metabolomics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Untargeted Metabolomics Revenue Market Share by Type (2027–2032)

Table 28. Global Untargeted Metabolomics Market Size by Application (US$ Million), 2021–2026

Table 29. Global Untargeted Metabolomics Revenue Market Share by Application (2021–2026)

Table 30. Global Untargeted Metabolomics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Untargeted Metabolomics Revenue Market Share by Application (2027–2032)

Table 32. North America Untargeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Untargeted Metabolomics Market Size by Country (US$ Million), 2021–2026

Table 34. North America Untargeted Metabolomics Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Untargeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Untargeted Metabolomics Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Untargeted Metabolomics Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Untargeted Metabolomics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Untargeted Metabolomics Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Untargeted Metabolomics Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Untargeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Untargeted Metabolomics Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Untargeted Metabolomics Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Untargeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Untargeted Metabolomics Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Untargeted Metabolomics Market Size by Country (US$ Million), 2027–2032

Table 47. Creative Dynamics Inc (Creative Proteomics) Company Details

Table 48. Creative Dynamics Inc (Creative Proteomics) Business Overview

Table 49. Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product

Table 50. Creative Dynamics Inc (Creative Proteomics) Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 51. Creative Dynamics Inc (Creative Proteomics) Recent Development

Table 52. Metabolon Company Details

Table 53. Metabolon Business Overview

Table 54. Metabolon Untargeted Metabolomics Product

Table 55. Metabolon Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 56. Metabolon Recent Development

Table 57. Alfa Chemistry Company Details

Table 58. Alfa Chemistry Business Overview

Table 59. Alfa Chemistry Untargeted Metabolomics Product

Table 60. Alfa Chemistry Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 61. Alfa Chemistry Recent Development

Table 62. Novelgene Technologies Company Details

Table 63. Novelgene Technologies Business Overview

Table 64. Novelgene Technologies Untargeted Metabolomics Product

Table 65. Novelgene Technologies Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 66. Novelgene Technologies Recent Development

Table 67. MtoZ-Biolabs Inc. Company Details

Table 68. MtoZ-Biolabs Inc. Business Overview

Table 69. MtoZ-Biolabs Inc. Untargeted Metabolomics Product

Table 70. MtoZ-Biolabs Inc. Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 71. MtoZ-Biolabs Inc. Recent Development

Table 72. CD Genomics Company Details

Table 73. CD Genomics Business Overview

Table 74. CD Genomics Untargeted Metabolomics Product

Table 75. CD Genomics Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 76. CD Genomics Recent Development

Table 77. Metware Biotechnology Inc (Metware) Company Details

Table 78. Metware Biotechnology Inc (Metware) Business Overview

Table 79. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product

Table 80. Metware Biotechnology Inc (Metware) Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 81. Metware Biotechnology Inc (Metware) Recent Development

Table 82. BGI Genomics Company Details

Table 83. BGI Genomics Business Overview

Table 84. BGI Genomics Untargeted Metabolomics Product

Table 85. BGI Genomics Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 86. BGI Genomics Recent Development

Table 87. APPLIED PROTEIN TECHNOLOGY Company Details

Table 88. APPLIED PROTEIN TECHNOLOGY Business Overview

Table 89. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product

Table 90. APPLIED PROTEIN TECHNOLOGY Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 91. APPLIED PROTEIN TECHNOLOGY Recent Development

Table 92. Suzhou PANOMIX Biomedical Tech Co.,Ltd Company Details

Table 93. Suzhou PANOMIX Biomedical Tech Co.,Ltd Business Overview

Table 94. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product

Table 95. Suzhou PANOMIX Biomedical Tech Co.,Ltd Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 96. Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Development

Table 97. OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details

Table 98. OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview

Table 99. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product

Table 100. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 101. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development

Table 102. Beijing Huayi innovation & BioTechnology Co., Ltd Company Details

Table 103. Beijing Huayi innovation & BioTechnology Co., Ltd Business Overview

Table 104. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product

Table 105. Beijing Huayi innovation & BioTechnology Co., Ltd Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 106. Beijing Huayi innovation & BioTechnology Co., Ltd Recent Development

Table 107. Abace Biotechnology Company Details

Table 108. Abace Biotechnology Business Overview

Table 109. Abace Biotechnology Untargeted Metabolomics Product

Table 110. Abace Biotechnology Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 111. Abace Biotechnology Recent Development

Table 112. Metabo-Profile Company Details

Table 113. Metabo-Profile Business Overview

Table 114. Metabo-Profile Untargeted Metabolomics Product

Table 115. Metabo-Profile Revenue in Untargeted Metabolomics Business (US$ Million), 2021–2026

Table 116. Metabo-Profile Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Untargeted Metabolomics Picture

Figure 2. Global Untargeted Metabolomics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Untargeted Metabolomics Market Share by Type: 2025 vs 2032

Figure 4. Plant Untargeted Metabolomics Features

Figure 5. Human Untargeted Metabolomics Features

Figure 6. Other Features

Figure 7. Global Untargeted Metabolomics Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Untargeted Metabolomics Market Share by Application: 2025 vs 2032

Figure 9. Academic and Research Institutions Case Studies

Figure 10. Pharmaceutical and Biotechnology Companies Case Studies

Figure 11. Untargeted Metabolomics Report Years Considered

Figure 12. Global Untargeted Metabolomics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Untargeted Metabolomics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Untargeted Metabolomics Market Share by Region: 2025 vs 2032

Figure 15. Global Untargeted Metabolomics Market Share by Players in 2025

Figure 16. Global Untargeted Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Untargeted Metabolomics Revenue in 2025

Figure 18. North America Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Untargeted Metabolomics Market Share by Country (2021–2032)

Figure 20. United States Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Untargeted Metabolomics Market Share by Country (2021–2032)

Figure 24. Germany Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Untargeted Metabolomics Market Share by Region (2021–2032)

Figure 32. China Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Untargeted Metabolomics Market Share by Country (2021–2032)

Figure 40. Mexico Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Untargeted Metabolomics Market Share by Country (2021–2032)

Figure 44. Israel Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Untargeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Creative Dynamics Inc (Creative Proteomics) Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 48. Metabolon Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 49. Alfa Chemistry Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 50. Novelgene Technologies Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 51. MtoZ-Biolabs Inc. Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 52. CD Genomics Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 53. Metware Biotechnology Inc (Metware) Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 54. BGI Genomics Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 55. APPLIED PROTEIN TECHNOLOGY Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 56. Suzhou PANOMIX Biomedical Tech Co.,Ltd Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 57. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 58. Beijing Huayi innovation & BioTechnology Co., Ltd Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 59. Abace Biotechnology Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 60. Metabo-Profile Revenue Growth Rate in Untargeted Metabolomics Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Metabolomics Kit Market Research Report 2024

Global Metabolomics Mixes and Kits Market Research Report 2024

Global Spatial Metabolomics Analysis Service Market Research Report 2025

Global Spatial Metabolomics Market Research Report 2024

Metabolomics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Metabolomics Reagents Market

Global Metabolomics Instrument Market Research Report 2024

Global Discovery Targeted Proteomics Service Market Research Report 2024

Global Spatial Mass Spectrometry Market Research Report 2024

Omics Based Clinical Trials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HPLC MS MS Detection System Market Research Report 2025

Global Discovery Bioanalysis Market Research Report 2024

Global Clinical Mass Spectrometry Market Research Report 2024

Global Custom Metabolite Synthesis Services Market Research Report 2024

Global Lipidomics Market Research Report 2024

Global Multiomics Market Research Report 2024

Global Metabolism Detection Kit Market Research Report 2024

Global Human Single Cell Multi Omics Market Research Report 2024

Global Targeted Proteomics Service Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions